Breaking News Bar

Business News and Information

Durham's BioCryst merging with Idera, moving some ops out of state

Durham’s BioCryst Pharmaceuticals (Nasdaq: BCRX) will merge with Exton, Pennsylvania-based Idera Pharmaceuticals (Nasdaq: IDRA) in an all-stock deal, the companies said Monday.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear